Open AccessLong Term Safety and Efficacy of Saroglitazar in Indian Patients with Diabetic Dyslipidemia and Very High Triglyceride Levels: Real World Evidence
Author(s) -
Arjun Baidya
Publication year - 2022
Publication title -
clinical diabetology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.152
H-Index - 4
eISSN - 2450-8187
pISSN - 2450-7458
DOI - 10.5603/dk.a2022.0039
Subject(s) - dyslipidemia , medicine , diabetes mellitus , glycemic , adverse effect , hypertriglyceridemia , triglyceride , creatinine , gastroenterology , endocrinology , cholesterol